The Latest Analyst Ratings For Ionis Pharmaceuticals
The Latest Analyst Ratings For Ionis Pharmaceuticals
ionis pharmaceuticals的最新分析师评级
The perception of Ionis Pharmaceuticals by...Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Ionis Pharmaceuticals (NASDAQ:IONS) in the last three months.
在过去的三个月里，共有6位分析师就Ionis Pharmaceuticals (NASDAQ:IONS)提供看好至看淡的多元化观点。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $66.17, a high estimate of $82.00, and a low estimate of $53.00. Marking an increase of 14.09%, the current average surpasses the previous average price target of $58.00.
分析师们分析了12个月的价值目标，平均目标为$66.17，最高估值为$82.00，最低估值为$53.00。当前的平均价值较之前的平均价值$58.00增加了14.09%。
Exploring Analyst Ratings: An In-Depth Overview
分析师评级:深入了解
The perception of Ionis Pharmaceuticals by...
专业人士对I...
登录免费看全文
登录/注册
资讯热榜
更新时间